Statistics

Total Visits

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis70

Select a period of time:

Number of views in the range

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis12

Views

Views
October 20253
November 20251
December 20252
January 20262
February 20260
March 20263
April 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil2
United Kingdom2
Mexico2
Argentina2
Spain1
United States1
Venezuela1
South Africa1
 

Top cities views

Views
Alegrete1
Cuiabá1
Córdoba1
Iztacalco1
Juárez1
Madrid1
Maracaibo1
Villa Ballester1